Skip to main content Patient Stories | YORVIPATH® (palopegteriparatide) Patient Site

This is Denise

“Coordinating chaos” with normal calcium levels

A self-described “chaos coordinator,” Denise fills her days with family, volunteering, and homeschooling her 2 boys. Initially, living with hypopara felt like she was “walking on a tightrope.” YORVIPATH fits into Denise’s daily routine and helps manage her blood calcium levels.

“YORVIPATH helps me manage my hypopara. I know it’s part of my daily routine with any of my medications and I go about my chaos coordinating for the day.”

This is Lynette

Staying active with managed hypopara

Lynette is a grandmother and retired special education teacher who loves being active. But her hypopara symptoms were interfering with her daily life. She and her doctor decided to try YORVIPATH so she can manage her calcium levels with fewer daily pills.

“With YORVIPATH, I don’t have the ups and downs with my calcium levels.”

Lynette’s journey with hypopara and YORVIPATH

Lynette was a special education teacher who enjoyed biking, sailing, camping, and running after her 6 grandchildren when she was diagnosed with hypopara after surgery for thyroid cancer.

Lynette was waking up multiple times each night to take her pills, and she still didn’t feel good. She missed her active lifestyle and being present for her husband, Tim (pictured), children, and grandchildren. She even had to give up her career in special education due to her hypopara symptoms.

Through a hypopara community group, she found a doctor who listened to her concerns and recommended she try YORVIPATH. It took time for Lynette to find her maintenance dose, but once she did, she began feeling better. With fewer daily calcium and vitamin D pills, she is able to manage her hypopara.

THIS IS Joanna

Living with fewer ups and downs

Joanna was diagnosed with hypopara when 2 of her parathyroid glands stopped working after an operation. As it worsened over time, Joanna had several hospitalizations and she felt like she was living in a body she couldn’t trust. That’s when her doctor recommended she try YORVIPATH.

“YORVIPATH seemed like the first prospect that could address the root cause of the disease.”

View Transcript +

Close Transcript -

Joanna: I’m Joanna, and I live in El Dorado Hills, California. I’m a therapist, a wife, and a mother, and I’ve been living with hypoparathyroidism since 2017. My diagnosis came after I had surgery for hyperparathyroidism, and it was tough. I was extremely unwell. They went in to take out 2 overactive parathyroid glands, and biopsy the other two. Unfortunately, as a result of the operation, the remaining 2 glands stopped working. This ultimately led to my hypoparathyroidism diagnosis. My doctors tried treating it in different ways, but it just worsened over time. I felt like I was living in a body I couldn’t trust. I was anxious all the time—constantly worried about where the nearest hospital was. I felt miserable and I wasn’t doing any activities. We used to love traveling and scuba diving, but the unpredictability of my hypoparathyroidism and the vulnerability it caused made it difficult for us to continue doing those things we once enjoyed. It didn’t just impact me—it impacted my husband and our sons. I felt like I wasn’t as present during big life events such as their middle and high school experiences, the dinners, and concerts—all those moments. I’ve always had a hunger for life, and my husband felt like he lost his buddy. He felt helpless that he couldn’t do anything.

Stephen: The hardest part for me is knowing how quickly she can go from looking perfectly fine to being in critical condition. I’m a doctor, and I was really not prepared for how much hypoparathyroidism would impact Joanna. We could never fully let our guard down—constantly having to stay ahead of it, trying to watch her calcium levels, anticipating issues before they escalate. The lack of understanding around the condition, even within the medical community, only adds to the challenge. You really have to advocate for yourself and your loved ones. Every time she ended up in the ER, it was an immense burden and took a heavy toll on our family.

Joanna: My work as a trauma therapist is also a huge part of my life, and my purpose. I care about my clients like family, and it was really hard for me to show up and be present for them. I did my best, but at times I was undependable. While I’ve always had compassion for others’ experiences, living through the trauma of hypoparathyroidism myself has deepened that compassion. I’ve had several hospitalizations due to full tetany—full-body rigidity, laryngospasms—just a complete shutdown of my muscles. Some were near-death experiences and were truly horrifying. After one of those experiences, my endocrinologist told me that because of the severity of my hypoparathyroidism, I was a “ticking time bomb” and that we needed to explore other treatment options.

Stephen: It was incredibly difficult to watch—I knew how much pain and anxiety Joanna was experiencing. We felt like we had to do something.

Joanna: That’s when we learned about YORVIPATH. I went to see my doctor, and she let me know about a treatment option under FDA review. YORVIPATH seemed like the first prospect that could address the root cause of the disease. After discussing the benefits and potential side effects, we decided that YORVIPATH was right for me, and I began treatment at the end of 2023. I know everyone’s experience will be different. But so far for me, the biggest difference is that I feel like I’m able to more predictably manage my hypoparathyroidism. There aren’t as many ups and downs, and the lows are less frequent. And rather than treating my hypoparathyroidism in ways that felt like putting Band-Aids on a big wound, I feel like we’re treating the root cause of it, and I like that. YORVIPATH has had a positive effect on how I am able to manage my hypoparathyroidism. I encourage all of you who are going through what I went through to talk to your doctor and see if it’s right for you, too. We’re all so eager to feel good, but getting there is a journey. As hypoparathyroidism patients, we must stay focused, take things one day at a time, advocate for ourselves, and seek out the best support available. For me, that includes my healthcare team and YORVIPATH. I feel so humbled by this disease. It’s made me more aware of just how beautiful life is, and how I want to live it. And I want that for everyone else living with hypoparathyroidism—that they can live their own full, amazing lives.

THIS IS Liz

Finding support through community

Liz struggled with her hypopara symptoms for years. Taking multiple pills daily was overwhelming and hard on Liz’s body. It was even harder to find a doctor who understood the disease and how to treat it. But once she did, Liz and her doctor decided that YORVIPATH was the right choice for her.

“I want to advocate for other people [with hypopara] if they can’t advocate for themselves. I just want people to get better.”

Liz’s journey with hypopara and YORVIPATH

After Liz had thyroid surgery, she knew something wasn’t right. Her fingers were stuck together, her whole body was tingling, and she felt scared. Six months later, she was diagnosed with hypopara.

Liz met with several doctors and was taking 32 pills a day to try to manage her symptoms. Her brain fog and fatigue made it hard to keep up with her 2 daughters, and she had multiple hospital stays. She felt frustrated and alone. But when she found a group for people with hypopara, things started to turn around. Through her group, Liz found understanding, support, and a specialist who recognized she needed another form of treatment.

Now that she’s taking YORVIPATH, Liz has fewer fluctuations in her calcium levels—and fewer daily pills. Liz enjoys daily walks, volunteering at dog rescues, and spending time with her family while managing her hypopara. She is active in her hypopara community and has found a passion for helping others feel less alone.

Register for updates

Fill out the form below to receive important information about YORVIPATH. If you’d like to connect with a Patient Access Liaison (PAL) for individualized support and education about hypopara and treatment with YORVIPATH, click the “Connect with a PAL” box.

*Required Field
*Required Field
*Required Field
*Required Field

Connect with a PAL

By checking this box, I confirm that I would like an Ascendis Patient Access Liaison to contact me with information about hypopara. I understand the PAL is not providing me medical advice and is not part of my healthcare team. I further certify that I am a resident of the United States and 18 years or older.

A PAL will reach out to you via phone.

*Required Field

Privacy Notice

By checking this box, I certify that I am a resident of the United States and 18 years or older and agree to Ascendis Pharma Terms of Use. I understand and agree that the information I provide will be used in line with the Ascendis Pharma Privacy Policy, including to provide me with marketing information, such as newsletters and updates, and to contact me for my opinion regarding products, programs, and services.

I understand that at any time I may unsubscribe by clicking on the designated link in the material.

close isi icon open isi icon

Important Safety Information and use

What is the most important information I should know about YORVIPATH?

YORVIPATH may cause serious side effects, including:

  • High levels of calcium in the blood (hypercalcemia). YORVIPATH can cause some people to have higher blood calcium levels than normal. Your healthcare provider should check your blood calcium before you start and during your treatment with YORVIPATH. Tell your healthcare provider right away if you have nausea, vomiting, dizziness, feeling thirsty, confusion, muscle weakness, or irregular heartbeat. Hypercalcemia is more likely to occur within the first 3 months of starting YORVIPATH, but it may occur at any time.
  • Low levels of calcium in the blood (hypocalcemia). People who stop using, miss, or change a dose of YORVIPATH may have an increased risk of low blood calcium levels, but hypocalcemia may occur at any time. Tell your healthcare provider right away if you have tingling in your fingertips, toes, lips or tongue, muscle spasms or cramps, oral numbness, depression, have problems thinking or remembering, abnormal heart rhythms, or seizures.

INDICATION AND LIMITATIONS OF USE

What is YORVIPATH® used for?

YORVIPATH is a prescription medicine used to treat adults with low parathyroid hormone (PTH) (hypoparathyroidism).

It is not known if YORVIPATH is safe and effective in people who have been recently diagnosed with hypoparathyroidism after surgery; if it is started in people with low levels of blood calcium; or in children. Do not use YORVIPATH in children and young adults whose bones are still growing.

  • Possible bone cancer (osteosarcoma). Tell your healthcare provider right away if you have pain in any areas of your body that does not go away or any new or unusual lumps or swelling under your skin that is tender to touch. These are some of the signs and symptoms of osteosarcoma and your healthcare provider may need to do further tests.

Who should not take YORVIPATH?

Do not use YORVIPATH if you are allergic to palopegteriparatide or any of the other ingredients in YORVIPATH.

What should I tell my healthcare provider before taking YORVIPATH?

Before using YORVIPATH, tell your healthcare provider about all of your medical conditions, including if you:

  • are at higher risk of a type of bone cancer called osteosarcoma. This is especially important:
    • if you have a bone disease that increases your risk of developing osteosarcoma (including if you have Paget’s disease).
    • if a blood test shows that you have unexplained increases in bone alkaline phosphatase.
    • if you have cancer of the bones or other cancer that has spread to your bones.
    • if you are having or have had radiation therapy to the skeleton.
    • if you are affected with a condition that runs in your family that can increase your chance of getting cancer in your bones.
  • take medicines that contain digoxin, are used to treat osteoporosis, or can affect calcium levels in your blood.
  • are pregnant or plan to become pregnant. It is not known if YORVIPATH will harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with YORVIPATH.
  • are breastfeeding or plan to breastfeed. It is not known if YORVIPATH passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with YORVIPATH.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. YORVIPATH and other medicines may affect each other causing side effects.

What are the possible side effects of YORVIPATH?

YORVIPATH may cause serious side effects:

  • Allergic (hypersensitivity) reaction, including anaphylaxis. Stop taking YORVIPATH and tell your healthcare provider or get emergency medical help right away if you have swelling of your face, lips, mouth, or tongue, breathing problems, fainting, dizziness, feeling lightheaded (low blood pressure), fast heartbeat, itching, rash, or hives.
  • Decrease in blood pressure when you change positions (orthostatic hypotension). Some people may feel dizzy, get a fast heartbeat, or feel light-headed right after injecting YORVIPATH. For the first few doses, give your injection of YORVIPATH in a place where you can sit or lie down right away if you get these symptoms. If your symptoms get worse or do not go away, contact your healthcare provider before you continue using YORVIPATH.
  • Digoxin toxicity if you are using digoxin and YORVIPATH at the same time. Tell your healthcare provider if you experience irregular heart rhythm, heart palpitations, confusion, loss of appetite, nausea, vomiting, diarrhea, or vision problems.

The most common side effects of YORVIPATH include injection site reactions, vasodilatory signs or symptoms such as a drop in blood pressure or lightheadedness when standing up, headache, diarrhea, back pain, high calcium levels, and sore throat.

These are not all of the possible side effects of YORVIPATH. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. You may also report side effects to Ascendis Pharma at 1-844-442-7236.

Please see the full Prescribing Information for YORVIPATH and the Medication Guide.

INDICATION AND LIMITATIONS OF USE

close isi icon open isi icon

What is YORVIPATH® used for?

YORVIPATH is a prescription medicine used to treat adults with low parathyroid hormone (PTH) (hypoparathyroidism).

It is not known if YORVIPATH is safe and effective in people who have been recently diagnosed with hypoparathyroidism after surgery; if it is started in people with low levels of blood calcium; or in children. Do not use YORVIPATH in children and young adults whose bones are still growing.

Important Safety Information and use

close isi icon open isi icon

What is the most important information I should know about YORVIPATH?

YORVIPATH may cause serious side effects, including:

  • High levels of calcium in the blood (hypercalcemia). YORVIPATH can cause some people to have higher blood calcium levels than normal. Your healthcare provider should check your blood calcium before you start and during your treatment with YORVIPATH. Tell your healthcare provider right away if you have nausea, vomiting, dizziness, feeling thirsty, confusion, muscle weakness, or irregular heartbeat. Hypercalcemia is more likely to occur within the first 3 months of starting YORVIPATH, but it may occur at any time.
  • Low levels of calcium in the blood (hypocalcemia). People who stop using, miss, or change a dose of YORVIPATH may have an increased risk of low blood calcium levels, but hypocalcemia may occur at any time. Tell your healthcare provider right away if you have tingling in your fingertips, toes, lips or tongue, muscle spasms or cramps, oral numbness, depression, have problems thinking or remembering, abnormal heart rhythms, or seizures.
  • Possible bone cancer (osteosarcoma). Tell your healthcare provider right away if you have pain in any areas of your body that does not go away or any new or unusual lumps or swelling under your skin that is tender to touch. These are some of the signs and symptoms of osteosarcoma and your healthcare provider may need to do further tests.

Who should not take YORVIPATH?

Do not use YORVIPATH if you are allergic to palopegteriparatide or any of the other ingredients in YORVIPATH.

What should I tell my healthcare provider before taking YORVIPATH?

Before using YORVIPATH, tell your healthcare provider about all of your medical conditions, including if you:

  • are at higher risk of a type of bone cancer called osteosarcoma. This is especially important:
    • if you have a bone disease that increases your risk of developing osteosarcoma (including if you have Paget’s disease).
    • if a blood test shows that you have unexplained increases in bone alkaline phosphatase.
    • if you have cancer of the bones or other cancer that has spread to your bones.
    • if you are having or have had radiation therapy to the skeleton.
    • if you are affected with a condition that runs in your family that can increase your chance of getting cancer in your bones.
  • take medicines that contain digoxin, are used to treat osteoporosis, or can affect calcium levels in your blood.
  • are pregnant or plan to become pregnant. It is not known if YORVIPATH will harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with YORVIPATH.
  • are breastfeeding or plan to breastfeed. It is not known if YORVIPATH passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with YORVIPATH.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. YORVIPATH and other medicines may affect each other causing side effects.

What are the possible side effects of YORVIPATH?

YORVIPATH may cause serious side effects:

  • Allergic (hypersensitivity) reaction, including anaphylaxis. Stop taking YORVIPATH and tell your healthcare provider or get emergency medical help right away if you have swelling of your face, lips, mouth, or tongue, breathing problems, fainting, dizziness, feeling lightheaded (low blood pressure), fast heartbeat, itching, rash, or hives.
  • Decrease in blood pressure when you change positions (orthostatic hypotension). Some people may feel dizzy, get a fast heartbeat, or feel light-headed right after injecting YORVIPATH. For the first few doses, give your injection of YORVIPATH in a place where you can sit or lie down right away if you get these symptoms. If your symptoms get worse or do not go away, contact your healthcare provider before you continue using YORVIPATH.
  • Digoxin toxicity if you are using digoxin and YORVIPATH at the same time. Tell your healthcare provider if you experience irregular heart rhythm, heart palpitations, confusion, loss of appetite, nausea, vomiting, diarrhea, or vision problems.

The most common side effects of YORVIPATH include injection site reactions, vasodilatory signs or symptoms such as a drop in blood pressure or lightheadedness when standing up, headache, diarrhea, back pain, high calcium levels, and sore throat.

These are not all of the possible side effects of YORVIPATH. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. You may also report side effects to Ascendis Pharma at 1-844-442-7236.

Please see the full Prescribing Information for YORVIPATH and the Medication Guide.

ER = emergency room; FDA = US Food and Drug Administration.

Please confirm you are a US resident.